Patents by Inventor Jeffrey B. Press

Jeffrey B. Press has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 4-?(thien-3-yl)methyl!-imidazole analgesics
    Patent number: 5750720
    Abstract: Described herein are 4-?(thien-3-yl)methyl!-imidazoles of the formula: ##STR1## wherein R is hydrogen or methyl, andX is C.sub.1-4 alkyl, bromine or chlorine; or ##STR2## wherein Y is hydrogen, C.sub.1-4 alkyl, bromine or chlorine, andZ is C.sub.1-4 4alkyl, bromine or chlorine which have exceptional analgesic activity.
    Type: Grant
    Filed: March 28, 1996
    Date of Patent: May 12, 1998
    Assignee: Ortho Pharmaceutical Corporation
    Inventors: Robert E. Boyd, Chris Royce Rasmussen, Jeffrey B. Press
  • 4-[(thien-2-yl)methyl]-imidazole analgesics
    Patent number: 5621113
    Abstract: The 4-[(thien-2-yl)methyl]-imidazoles of the formulae: ##STR1## wherein R is hydrogen or methyl,X is hydrogen, C.sub.1-4 alkyl, bromine or chlorine, andY is hydrogen, C.sub.1-4 alkyl, bromine or chlorine;with the proviso that X and Y are not both simultaneously hydrogen.have exceptional analgesic activity.
    Type: Grant
    Filed: March 28, 1996
    Date of Patent: April 15, 1997
    Assignee: Ortho Pharmaceutical Corporation
    Inventors: Robert E. Boyd, Chris R. Rasmussen, Jeffrey B. Press
  • Substituted thienopyrans as antihypertensive agents
    Patent number: 5260453
    Abstract: Substituted thienopyrans and processes for preparing the thienopyrans are disclosed.
    Type: Grant
    Filed: November 5, 1990
    Date of Patent: November 9, 1993
    Assignee: Ortho Pharmaceutical Corporation
    Inventors: Jeffrey B. Press, Pauline Sanfilippo, James J. McNally, Robert Falotico
  • Substituted benzhydryl 2-hydroxypropyl piperazine derivatives
    Patent number: 5215987
    Abstract: Substituted benzhydryl 2-hydroxypropyl piperazine derivatives and methods of synthesis of the derivatives are described. The substituted benzhydryl 2-hydroxypropyl piperazine derivatives are useful as cardiotonic agents.
    Type: Grant
    Filed: April 23, 1990
    Date of Patent: June 1, 1993
    Assignee: Ortho Pharmaceutical Corporation
    Inventors: Zoltan G. Hajos, Ramesh M. Kanojia, Jeffrey B. Press
  • 2- or 3-aryl substituted imidazo[1,2-a]pyridines
    Patent number: 4833149
    Abstract: Novel 2- or 3-aryl substituted imidazo[1,2-a]pyridines and their synthesis are described. The compounds have local anesthetic properties and are useful as local anesthetic agents, calcium channel blocking agents and antisecretory agents.
    Type: Grant
    Filed: April 15, 1988
    Date of Patent: May 23, 1989
    Assignee: Ortho Pharmaceutical Corporation
    Inventor: Jeffrey B. Press
  • Process for the preparation of 8-halo-5,6-dialkoxyquinazoline-2,4-diones and their salts
    Patent number: 4634769
    Abstract: A process for the preparation of 8-halo-5,6-dialkoxyquinazoline-2,4-diones and their metal salts is described. The diones are active cardiotonic agents.
    Type: Grant
    Filed: September 25, 1984
    Date of Patent: January 6, 1987
    Assignee: Ortho Pharmaceutical Corporation
    Inventors: Victor T. Bandurco, Robert A. Mallory, Jeffrey B. Press, Harvey M. Werblood
  • N-[2-4-(1H-Imidazol-1-yl)alkyl]-arylamides and pharmaceutical compositions
    Patent number: 4568687
    Abstract: This disclosure describes novel N-[.omega.-(1H-imidazol-1-yl)alkyl]arylamides which possess the property of inhibiting the enzyme thromboxane synthetase and are also useful in the treatment of hypertension and myocardial ischemia.
    Type: Grant
    Filed: January 13, 1984
    Date of Patent: February 4, 1986
    Assignee: American Cyanamid Company
    Inventors: William B. Wright, Jr., Jeffrey B. Press
  • Substituted N-[.omega.-(1H-imidazol-1-yl)alkyl]-amides
    Patent number: 4489089
    Abstract: This disclosure describes novel N-[.omega.-(1H-imidazol-1-yl)alkyl]amides which possess the property of inhibiting the enzyme thromboxane synthetase.
    Type: Grant
    Filed: January 13, 1984
    Date of Patent: December 18, 1984
    Assignee: American Cyanamid Company
    Inventors: William B. Wright, Jr., Jeffrey B. Press